Envíos recientes

AptamerRunner: An accessible aptamer structure prediction and clustering algorithm for visualization of selected aptamers

Ruiz Ciancio, Dario; Veeramani, Suresh; Singh, Rahul; Embree, Eric; Ortman, Chris; Thiel, Kristina (Elsevier, 2024-12-10)

Spartalizumab in combination with platinum-doublet chemotherapy with or without canakinumab in patients with PD-L1-unselected, metastatic NSCLC

Garrido López, Pilar; Zugazagoitia, Jon; Shepherd, Frances; Santoro, Armando; Tan, Daniel; bearz, alessandra; FELIP, ENRIQUETA (BMC, 2024-10-24)

The TALAPRO-3 study design: a plain language summary

Saad, Fred; Matsubara, Nobuaki; Agarwal, Neeraj; Azad, Arun; Shore, Neal; Mateo, Joaquin (Taylor & Francis, 2024)

ESMO Resilience Task Force recommendations to manage psychosocial risks, optimise well-being, and reduce burnout in oncology

KAMPOSIORAS, KONSTANTNOS; Haanen, John; Hardy, Claire; Murali, Krithika; Lim, Kok Haw Jonathan; Elez, Elena (Elsevier, 2024-10)

Association of Tumor Mutational Burden and PD-L1 with the Efficacy of Pembrolizumab with or without Chemotherapy versus Chemotherapy in Advanced Urothelial Carcinoma

Fléchon, Aude; ALVA, AJJAI; Powles, Thomas; ÖZGÜROGLU, MUSTAFA; Csoszi, Tibor; Morales-Barrera, Rafael (American Association for Cancer Research, 2024-12-01)

Scientia. Depósito de Información Digital del Departamento de Salud

VHIO - Articles científics: Envíos recientes

AptamerRunner: An accessible aptamer structure prediction and clustering algorithm for visualization of selected aptamers

Spartalizumab in combination with platinum-doublet chemotherapy with or without canakinumab in patients with PD-L1-unselected, metastatic NSCLC

The TALAPRO-3 study design: a plain language summary

ESMO Resilience Task Force recommendations to manage psychosocial risks, optimise well-being, and reduce burnout in oncology

Association of Tumor Mutational Burden and PD-L1 with the Efficacy of Pembrolizumab with or without Chemotherapy versus Chemotherapy in Advanced Urothelial Carcinoma

Scientia. Depósito de Información Digital del Departamento de Salud

VHIO - Articles científics: Envíos recientes

AptamerRunner: An accessible aptamer structure prediction and clustering algorithm for visualization of selected aptamers ﻿

Spartalizumab in combination with platinum-doublet chemotherapy with or without canakinumab in patients with PD-L1-unselected, metastatic NSCLC ﻿

The TALAPRO-3 study design: a plain language summary ﻿

ESMO Resilience Task Force recommendations to manage psychosocial risks, optimise well-being, and reduce burnout in oncology ﻿

Association of Tumor Mutational Burden and PD-L1 with the Efficacy of Pembrolizumab with or without Chemotherapy versus Chemotherapy in Advanced Urothelial Carcinoma ﻿

AptamerRunner: An accessible aptamer structure prediction and clustering algorithm for visualization of selected aptamers

Spartalizumab in combination with platinum-doublet chemotherapy with or without canakinumab in patients with PD-L1-unselected, metastatic NSCLC

The TALAPRO-3 study design: a plain language summary

ESMO Resilience Task Force recommendations to manage psychosocial risks, optimise well-being, and reduce burnout in oncology

Association of Tumor Mutational Burden and PD-L1 with the Efficacy of Pembrolizumab with or without Chemotherapy versus Chemotherapy in Advanced Urothelial Carcinoma